Trial intelligence / Profile preview

Effects of Epicatechin on Statin-induced Mitochondrial Dysfunction

NCT02490527Completed

Sponsor
University of California, San Diego
Start
Jun 2015
Primary completion
Jul 2021
Countries
1
01

Overview

Randomised, double-blind trial in statin intolerance (SAMS) (2 arms), sponsored by University of California, San Diego. Primary endpoint: Functional Capacity (VO2max) at 3 months. Started Jun 2015; status: completed.

02

Conditions

statin intolerance (SAMS)

Beyond the preview

Go deeper on NCT02490527.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02490527.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call